Cassava Sciences said that its drug did not significantly reduce cognitive decline in 1,900 people with mild to moderate ...

Investigational simufilam failed to reduce cognitive or functional decline in Alzheimer's disease patients in the ReThink-ALZ ...

Alzheimer’s is the most common type of dementia. Music therapy can improve mood and cognitive performance in Alzheimer’s ...

The International Working Group discussed diagnosing Alzheimer's disease among cognitively unimpaired individuals in a ...

(Reuters) -Cassava Sciences said it will stop all trials of its Alzheimer's disease drug after it failed a late-stage study, ...

A decade ago, researchers introduced a new model for studying Alzheimer's disease. Known as "Alzheimer's in a dish," the ...

Stay alert with list of early signs and symptoms of dementia that disrupts daily life and may be a symptom of Alzheimer’s or ...

Tau behaves abnormally in the brain in people with Alzheimer’s disease. This latest study points to a reason why.

A new study from the University of Liverpool represents a significant step forward in scientists' understanding of Alzheimer's disease.

LAS VEGAS (KTNV) — November is National Alzheimer’s Awareness Month, and this year, experts are shining a light on a growing ...

The active agent in the nasal spray, 2-bromopalmitate, carries a high risk of interfering with a number of processes, making ...

Subtle signs of Alzheimer's disease can emerge decades before a diagnosis—often in the form of irregular behaviors that ...